{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:16:11Z","timestamp":1790100971109,"version":"4.0.1"},"reference-count":104,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Neuroscience"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/00207454.2026.2620698","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:11:27Z","timestamp":1769145087000},"page":"650-664","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["A patent review on traumatic brain injuries (2020\u20132025)"],"prefix":"10.1080","volume":"136","author":[{"given":"Khyati","family":"Sharma","sequence":"first","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, All India Institute of Medical Sciences","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Gabrani","sequence":"additional","affiliation":[{"name":"Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2025.01.001"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2021.101599"},{"issue":"11","key":"e_1_3_3_5_1","first-page":"2788","article-title":"Barbiturate coma in patients with severe traumatic brain injury: a multicenter cohort study","volume":"41","author":"Turgeon AF","year":"2013","unstructured":"Turgeon AF, Lauzier F, Simard JF, et al. Barbiturate coma in patients with severe traumatic brain injury: a multicenter cohort study. Crit Care Med. 2013;41(11):2788\u20132796.","journal-title":"Crit Care Med"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30279-X"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/bios11090319"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2024.2306876"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.887898"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2015.1040762"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009985"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63020"},{"key":"e_1_3_3_13_1","article-title":"Systems and methods for using eye imaging on a wearable device to assess human health","author":"Krueger WWO.","year":"2025","unstructured":"Krueger WWO. Systems and methods for using eye imaging on a wearable device to assess human health. US12383178B2. 2025.","journal-title":"US12383178B2"},{"key":"e_1_3_3_14_1","article-title":"Elastically deformable components and assemblies for use in cellular assays","author":"Balachandran K","year":"2025","unstructured":"Balachandran K, Sturdivant NM. Elastically deformable components and assemblies for use in cellular assays. US12319903B2. 2025.","journal-title":"US12319903B2"},{"key":"e_1_3_3_15_1","article-title":"Methods and materials for identifying and treating traumatic brain injury","author":"Puffer RC","year":"2024","unstructured":"Puffer RC, Parney IF. Methods and materials for identifying and treating traumatic brain injury. US12091716B2. 2024.","journal-title":"US12091716B2"},{"key":"e_1_3_3_16_1","article-title":"Methods and kits for detection of blast brain injury, its severity, distance from blast epicenter, and classification relative to the larger spectrum of concussion","author":"Samadani U","year":"2024","unstructured":"Samadani U, Zahid AB. Methods and kits for detection of blast brain injury, its severity, distance from blast epicenter, and classification relative to the larger spectrum of concussion. US11937935B2. 2024.","journal-title":"US11937935B2"},{"key":"e_1_3_3_17_1","article-title":"In vitro method for diagnosing central nervous system injury","author":"Ah C-B.","year":"2022","unstructured":"Ah C-B. In vitro method for diagnosing central nervous system injury. EP4100060B1. 2022.","journal-title":"EP4100060B1"},{"key":"e_1_3_3_18_1","article-title":"Systems and methods for detecting a brain condition","author":"Peterson GK","year":"2022","unstructured":"Peterson GK, Nelson JT, Sherwood GJ. Systems and methods for detecting a brain condition. US11442056B2. 2022.","journal-title":"US11442056B2"},{"key":"e_1_3_3_19_1","article-title":"Lateral flow assay device for traumatic brain injury diagnosis using time-resolved fluorescence analysis, and method for diagnosing traumatic brain injury by using same","author":"Kang J","year":"2021","unstructured":"Kang J, Hwang KY, Park JM, et al. Lateral flow assay device for traumatic brain injury diagnosis using time-resolved fluorescence analysis, and method for diagnosing traumatic brain injury by using same. EP3916387B1. 2021.","journal-title":"EP3916387B1"},{"key":"e_1_3_3_20_1","article-title":"Methods for detecting traumatic brain injury","author":"Sierks M","year":"2021","unstructured":"Sierks M, Williams S. Methods for detecting traumatic brain injury. US11175584B2. 2021.","journal-title":"US11175584B2"},{"key":"e_1_3_3_21_1","article-title":"Compositions and methods for treating brain injury","author":"Rosi S","year":"2021","unstructured":"Rosi S, Krukowski K, Yednock T, et al. Compositions and methods for treating brain injury. EP3873525B1. 2021.","journal-title":"EP3873525B1"},{"key":"e_1_3_3_22_1","article-title":"Device for treatment of traumatic brain injury","author":"Devens D","year":"2021","unstructured":"Devens D, Goodwin K, Smith WS, et al. Device for treatment of traumatic brain injury. EP3784324B1. 2021.","journal-title":"EP3784324B1"},{"key":"e_1_3_3_23_1","article-title":"Analysis and prediction of traumatic brain injury and concusion symptoms","author":"Hicks SD","year":"2020","unstructured":"Hicks SD, Middleton FA, Uhlig R. Analysis and prediction of traumatic brain injury and concusion symptoms. EP3600472B1. 2020.","journal-title":"EP3600472B1"},{"key":"e_1_3_3_24_1","article-title":"A method for diagnosis of traumatic brain injury","author":"V\u00e4limaa L","year":"2025","unstructured":"V\u00e4limaa L, Harel A, Haavisto O, et al. A method for diagnosis of traumatic brain injury. EP4483187B1. 2025.","journal-title":"EP4483187B1"},{"key":"e_1_3_3_25_1","article-title":"Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers","author":"McQuiston B","year":"2024","unstructured":"McQuiston B, Rogers J, Datwyler S, et al. Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers. US12099069B2. 2024.","journal-title":"US12099069B2"},{"key":"e_1_3_3_26_1","article-title":"Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers","author":"McQuiston B","year":"2024","unstructured":"McQuiston B, Rogers J, Marino J, et al. Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers. US12092647B2. 2024.","journal-title":"US12092647B2"},{"key":"e_1_3_3_27_1","article-title":"Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject","author":"McQuiston B","year":"2024","unstructured":"McQuiston B, Rogers J, Datwyler S, et al. Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject. US12085567B2. 2024.","journal-title":"US12085567B2"},{"key":"e_1_3_3_28_1","article-title":"Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods","author":"Catania M","year":"2024","unstructured":"Catania M, Hayes RL. Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods. US12077601B2. 2024.","journal-title":"US12077601B2"},{"key":"e_1_3_3_29_1","unstructured":"Wang KKW Hayes RL Mueller UR Zhang Z. Biomarker detection process and assay of neurological condition. US11994522B2. 2024."},{"key":"e_1_3_3_30_1","article-title":"Protein biomarker indicators of neurological injury and\/or disease and methods of use thereof","author":"Meter TEV.","year":"2024","unstructured":"Meter TEV. Protein biomarker indicators of neurological injury and\/or disease and methods of use thereof. US11988676B2. 2024.","journal-title":"US11988676B2"},{"key":"e_1_3_3_31_1","article-title":"Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers","author":"McQuiston B","year":"2024","unstructured":"McQuiston B, Korley F, Beshiri A, et al. Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers. US11931161B2. 2024.","journal-title":"US11931161B2"},{"key":"e_1_3_3_32_1","article-title":"Neural proteins as biomarkers for nervous system injury and other neural disorders","author":"Wang KKW","year":"2022","unstructured":"Wang KKW, Oli M, Liu MC. Neural proteins as biomarkers for nervous system injury and other neural disorders. US11221342B2. 2022.","journal-title":"US11221342B2"},{"key":"e_1_3_3_33_1","article-title":"Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I","author":"McQuiston B","year":"2021","unstructured":"McQuiston B, Korley F, Beshiri A, et al. Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I. US11129564B2. 2021.","journal-title":"US11129564B2"},{"key":"e_1_3_3_34_1","article-title":"Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers","author":"McQuiston B","year":"2020","unstructured":"McQuiston B, Rogers J, Datwyler S, et al. Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers. US10877048B2. 2020.","journal-title":"US10877048B2"},{"key":"e_1_3_3_35_1","article-title":"Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject","author":"McQuiston B","year":"2020","unstructured":"McQuiston B, Rogers J, Datwyler S, et al. Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject. US10877038B2. 2020.","journal-title":"US10877038B2"},{"key":"e_1_3_3_36_1","article-title":"Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers","author":"McQuiston B","year":"2020","unstructured":"McQuiston B, Korley F, Beshiri A, et al. Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers. US10849548B2. 2020.","journal-title":"US10849548B2"},{"key":"e_1_3_3_37_1","article-title":"Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries","author":"Jensen KVK","year":"2020","unstructured":"Jensen KVK, Huentelman M, Yeri A. Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries. US10809271B2. 2020.","journal-title":"US10809271B2"},{"key":"e_1_3_3_38_1","article-title":"Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system","author":"Wang KKW","year":"2020","unstructured":"Wang KKW, Yang Z, Moghieb A, et al. Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system. US10725054B2. 2020.","journal-title":"US10725054B2"},{"key":"e_1_3_3_39_1","article-title":"Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury","author":"Van Eyk J","year":"2020","unstructured":"Van Eyk J, McQuiston B, Datwyler S, et al. Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury. EP3732489B1. 2020.","journal-title":"EP3732489B1"},{"key":"e_1_3_3_40_1","article-title":"Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system","author":"Wang KK","year":"2020","unstructured":"Wang KK, Yang Z, Moghieb A, et al. Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system. EP3663764B1. 2020.","journal-title":"EP3663764B1"},{"key":"e_1_3_3_41_1","article-title":"Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject","author":"McQuiston B","year":"2020","unstructured":"McQuiston B, Rogers J, Datwyler S, et al. Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject. EP3635407B1. 2020.","journal-title":"EP3635407B1"},{"key":"e_1_3_3_42_1","article-title":"Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers","author":"McQuiston B","year":"2020","unstructured":"McQuiston B, Rogers J, Datwyler S, et al. Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers. EP3610268B1. 2020.","journal-title":"EP3610268B1"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0887-8"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad304"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2015.4373"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13899"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.825086"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.08.058"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.12.046"},{"key":"e_1_3_3_50_1","article-title":"Methods and compositions for restoring STMN2 levels","author":"Eggan KC","year":"2025","unstructured":"Eggan KC, Klim JR, Limone F, et al. Methods and compositions for restoring STMN2 levels. US12496327B2. 2025.","journal-title":"US12496327B2"},{"key":"e_1_3_3_51_1","article-title":"Inhibitors of mPTP","author":"Miller N","year":"2025","unstructured":"Miller N, Ouvry G, Rutter R, et al. Inhibitors of mPTP. US12491185B2. 2025.","journal-title":"US12491185B2"},{"key":"e_1_3_3_52_1","article-title":"Substituted pyrazolo-pyrimidines and uses thereof","author":"Rosen MD","year":"2025","unstructured":"Rosen MD, Galemmo RAJr, Liang W, et al. Substituted pyrazolo-pyrimidines and uses thereof. US12486274B2. 2025.","journal-title":"US12486274B2"},{"key":"e_1_3_3_53_1","article-title":"Devices, systems and methods for cortical stimulation","author":"Moran DW","year":"2025","unstructured":"Moran DW, Leuthardt EC, Gribetz M. Devices, systems and methods for cortical stimulation. US12485277B2. 2025.","journal-title":"US12485277B2"},{"key":"e_1_3_3_54_1","article-title":"Progesterone analogs and uses related thereto","author":"Guthrie DB","year":"2025","unstructured":"Guthrie DB, Lockwood MA, Liotta DC, et al. Progesterone analogs and uses related thereto. US12459970B2. 2025.","journal-title":"US12459970B2"},{"key":"e_1_3_3_55_1","article-title":"Beta adrenergic agonist and methods of using the same","author":"Ford AP","year":"2025","unstructured":"Ford AP, Chen W, Carter DS, et al. Beta adrenergic agonist and methods of using the same. US12448352B2. 2025.","journal-title":"US12448352B2"},{"key":"e_1_3_3_56_1","article-title":"Pharmaceutical use of FAM19A5 involved in regulating gliogenesis","author":"Seong JY","year":"2025","unstructured":"Seong JY, Hwang JI, Sun W, et al. Pharmaceutical use of FAM19A5 involved in regulating gliogenesis. US12435130B2. 2025.","journal-title":"US12435130B2"},{"key":"e_1_3_3_57_1","article-title":"RNA-binding protein multimerization inhibitors and methods of use thereof","author":"Nabors LB","year":"2025","unstructured":"Nabors LB, Filippova N, Yang X, et al. RNA-binding protein multimerization inhibitors and methods of use thereof. US12435091B2. 2025.","journal-title":"US12435091B2"},{"key":"e_1_3_3_58_1","article-title":"Compositions and methods for treating CNS disorders","author":"Robichaud AJ","year":"2025","unstructured":"Robichaud AJ, Salituro FG, Pillado MJB, et al. Compositions and methods for treating CNS disorders. US12421275B2. 2025.","journal-title":"US12421275B2"},{"key":"e_1_3_3_59_1","article-title":"Progesterone phosphate analogs and uses related thereto","author":"Guthrie DB","year":"2025","unstructured":"Guthrie DB, Lockwood MA, Natchus MG, et al. Progesterone phosphate analogs and uses related thereto. US12415829B2. 2025.","journal-title":"US12415829B2"},{"key":"e_1_3_3_60_1","article-title":"Methods of treating brain disorders","author":"Greene DA","year":"2025","unstructured":"Greene DA, Ratan RR, Bradshaw TI. Methods of treating brain disorders. US12414929B2. 2025.","journal-title":"US12414929B2"},{"key":"e_1_3_3_61_1","article-title":"Mitofusin activators and methods of use thereof","author":"Dorn GW.","year":"2025","unstructured":"Dorn GW.II. Mitofusin activators and methods of use thereof. US12409157B2. 2025.","journal-title":"US12409157B2"},{"key":"e_1_3_3_62_1","article-title":"Cromolyn esters and uses thereof","author":"Elmaleh DR","year":"2025","unstructured":"Elmaleh DR, Shoup TM. Cromolyn esters and uses thereof. US12383528B2. 2025.","journal-title":"US12383528B2"},{"key":"e_1_3_3_63_1","article-title":"Targeted nanoparticle for the treatment of traumatic brain injury and other CNS diseases","author":"Perumal V","year":"2025","unstructured":"Perumal V, Ravula AR, Chandra N, et al. Targeted nanoparticle for the treatment of traumatic brain injury and other CNS diseases. US12329765B2. 2025.","journal-title":"US12329765B2"},{"key":"e_1_3_3_64_1","article-title":"Brain immunoregulation through transcranial electromagnetic treatment","author":"Arendash GW.","year":"2025","unstructured":"Arendash GW. Brain immunoregulation through transcranial electromagnetic treatment. US12318624B2. 2025.","journal-title":"US12318624B2"},{"key":"e_1_3_3_65_1","article-title":"Leucine-enriched ketogenic formulations","author":"Gingrich S","year":"2025","unstructured":"Gingrich S, Reed R, Nagao K, et al. Leucine-enriched ketogenic formulations. US12257221B2. 2025.","journal-title":"US12257221B2"},{"key":"e_1_3_3_66_1","article-title":"Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes","author":"West T","year":"2025","unstructured":"West T, Paoletti AC. Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes. US12253529B2. 2025.","journal-title":"US12253529B2"},{"key":"e_1_3_3_67_1","article-title":"Method for treating nervous system injuries using boldine and derivatives thereof","author":"Cardozo C","year":"2025","unstructured":"Cardozo C, Chacon CAT, Graham Z, et al. Method for treating nervous system injuries using boldine and derivatives thereof. US12246012B2. 2025.","journal-title":"US12246012B2"},{"key":"e_1_3_3_68_1","article-title":"Compounds and methods for treating neurological and cardiovascular conditions","author":"Korinek WS","year":"2025","unstructured":"Korinek WS, Lechleiter JD, Liston TE, et al. Compounds and methods for treating neurological and cardiovascular conditions. US12239654B2. 2025.","journal-title":"US12239654B2"},{"key":"e_1_3_3_69_1","article-title":"Methods of intravenous administration of glyburide","author":"Jacobson SM.","year":"2025","unstructured":"Jacobson SM. Methods of intravenous administration of glyburide. US12226521B2. 2025.","journal-title":"US12226521B2"},{"key":"e_1_3_3_70_1","article-title":"Compounds for the treatment or alleviation of disorders associated with Tau aggregates","author":"Nampally S","year":"2025","unstructured":"Nampally S, Gabellieri E, Molette J, et al. Compounds for the treatment or alleviation of disorders associated with Tau aggregates. US12202840B2. 2025.","journal-title":"US12202840B2"},{"key":"e_1_3_3_71_1","article-title":"Methods of treating patients suffering from brain injury and methods of increasing the value of the extended Glasgow Outcome Scale of patients suffering from brain injury","author":"Stover J","year":"2024","unstructured":"Stover J, Tegtmeier F. Methods of treating patients suffering from brain injury and methods of increasing the value of the extended Glasgow Outcome Scale of patients suffering from brain injury. US12171766B2. 2024.","journal-title":"US12171766B2"},{"key":"e_1_3_3_72_1","article-title":"Compounds and use thereof for the treatment of diseases associated with impaired p-galactosidase activity","author":"Virginie R","year":"2024","unstructured":"Virginie R, Roger M, M\u00e9lanie D, et al. Compounds and use thereof for the treatment of diseases associated with impaired p-galactosidase activity. EP4463445B1. 2024.","journal-title":"EP4463445B1"},{"key":"e_1_3_3_73_1","article-title":"Therapy using a factor XII inhibitor in a neurotraumatic disorder","author":"Kleinschnitz C","year":"2024","unstructured":"Kleinschnitz C, Nolte M, Sir\u00e9n AL, et al. Therapy using a factor XII inhibitor in a neurotraumatic disorder. US12065481B2. 2024.","journal-title":"US12065481B2"},{"key":"e_1_3_3_74_1","article-title":"Hyaluronidase for the prevention, treatment, reduction and\/or abolishment of cerebral edema and intracranial pressure","author":"Morrison B","year":"2024","unstructured":"Morrison BIII, Kernie S, Walker P. Hyaluronidase for the prevention, treatment, reduction and\/or abolishment of cerebral edema and intracranial pressure. US12042528B2. 2024.","journal-title":"US12042528B2"},{"key":"e_1_3_3_75_1","article-title":"Low-dose radiation therapy for traumatic brain injury and stroke","author":"Ma CHE","year":"2024","unstructured":"Ma CHE, Au NPB. Low-dose radiation therapy for traumatic brain injury and stroke. US11986525B2. 2024.","journal-title":"US11986525B2"},{"key":"e_1_3_3_76_1","article-title":"19-nor neuroactive steroids and methods of use thereof","author":"Botella GM","year":"2024","unstructured":"Botella GM, Harrison BL, Robichaud AJ, et al. 19-nor neuroactive steroids and methods of use thereof. US11912737B2. 2024.","journal-title":"US11912737B2"},{"key":"e_1_3_3_77_1","article-title":"Compositions and methods for treating traumatic brain injury","author":"Carver C.","year":"2024","unstructured":"Carver C. Compositions and methods for treating traumatic brain injury. US11878012B2. 2024.","journal-title":"US11878012B2"},{"key":"e_1_3_3_78_1","article-title":"Methods for treating brain injury","author":"Liu DZ.","year":"2023","unstructured":"Liu DZ. Methods for treating brain injury. US11667920B2. 2023.","journal-title":"US11667920B2"},{"key":"e_1_3_3_79_1","article-title":"Amino acid compositions and their use for the treatment of traumatic brain injury","author":"Carroll S","year":"2023","unstructured":"Carroll S, Afeyan R, Rienzo GD, et al. Amino acid compositions and their use for the treatment of traumatic brain injury. US11617731B2. 2023.","journal-title":"US11617731B2"},{"key":"e_1_3_3_80_1","article-title":"Methods for improving neurological diseases and disorders","author":"Ford AP","year":"2023","unstructured":"Ford AP, Vargas G. Methods for improving neurological diseases and disorders. US11607395B2. 2023.","journal-title":"US11607395B2"},{"key":"e_1_3_3_81_1","article-title":"Stable diglyceride emulsions and methods for treating organ injury","author":"Richard DJ","year":"2023","unstructured":"Richard DJ, Liz CC, Hylde Z. Stable diglyceride emulsions and methods for treating organ injury. EP4135684B1. 2023.","journal-title":"EP4135684B1"},{"key":"e_1_3_3_82_1","article-title":"Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides","author":"Dowling PC","year":"2023","unstructured":"Dowling PC, Wang B, Yuan RR, et al. Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides. US11559565B2. 2023.","journal-title":"US11559565B2"},{"key":"e_1_3_3_83_1","article-title":"Methods for protecting and treating traumatic brain injury, concussion, and brain inflammation with intranasal insulin","author":"Frey WH","year":"2023","unstructured":"Frey WH, 2nd, Hanson LRB, Byrnes K, et al. Methods for protecting and treating traumatic brain injury, concussion, and brain inflammation with intranasal insulin. US11559579B2. 2023.","journal-title":"US11559579B2"},{"key":"e_1_3_3_84_1","article-title":"Compounds and compositions for targeting brain injuries and methods of use thereof","author":"Ruoslahti E","year":"2022","unstructured":"Ruoslahti E, Mann A, Scodeller P, et al. Compounds and compositions for targeting brain injuries and methods of use thereof. US11458210B2. 2022.","journal-title":"US11458210B2"},{"key":"e_1_3_3_85_1","article-title":"Reducing the risk of pathological effects of traumatic brain injury","author":"Hadley K","year":"2022","unstructured":"Hadley K, Fealey T, Bailes JE. Reducing the risk of pathological effects of traumatic brain injury. US11413263B2. 2022.","journal-title":"US11413263B2"},{"key":"e_1_3_3_86_1","article-title":"Compositions and methods for treating nervous system injuries","author":"Ruoslahti E","year":"2022","unstructured":"Ruoslahti E, Hussain S, Mann APS, et al. Compositions and methods for treating nervous system injuries. US11376303B2. 2022.","journal-title":"US11376303B2"},{"key":"e_1_3_3_87_1","article-title":"Method for treatment of traumatic brain injury targeting aggregated peptides","author":"Lannfelt L","year":"2022","unstructured":"Lannfelt L, Basun H, Waara ER. Method for treatment of traumatic brain injury targeting aggregated peptides. US11327080B2. 2022.","journal-title":"US11327080B2"},{"key":"e_1_3_3_88_1","article-title":"Methods of delivering a neuroprotective polypeptide to the central nervous system","author":"Kim DS","year":"2022","unstructured":"Kim DS, Kim HK, Greig NH. Methods of delivering a neuroprotective polypeptide to the central nervous system. US11273130B2. 2022.","journal-title":"US11273130B2"},{"key":"e_1_3_3_89_1","article-title":"Methods of treating mild brain injury","author":"Bansal V.","year":"2022","unstructured":"Bansal V. Methods of treating mild brain injury. US11241483B2. 2022.","journal-title":"US11241483B2"},{"key":"e_1_3_3_90_1","article-title":"(N-)acetyl-l-leucine for use in treating traumatic brain injury","author":"Factor M","year":"2022","unstructured":"Factor M, Fields T. (N-)acetyl-l-leucine for use in treating traumatic brain injury. EP3934637B1. 2022.","journal-title":"EP3934637B1"},{"key":"e_1_3_3_91_1","article-title":"Compositions and methods for treating traumatic brain injury","author":"Baguisi A","year":"2022","unstructured":"Baguisi A, Beeuwkes R, Casale R, et al. Compositions and methods for treating traumatic brain injury. US11213509B2. 2022.","journal-title":"US11213509B2"},{"key":"e_1_3_3_92_1","article-title":"Neuroprotective quinoline sulfonamides","author":"Dahl R.","year":"2022","unstructured":"Dahl R. Neuroprotective quinoline sulfonamides. US11213701B2. 2022.","journal-title":"US11213701B2"},{"key":"e_1_3_3_93_1","article-title":"Compositions and methods for the treatment of neurodamage","author":"Barnea ER.","year":"2021","unstructured":"Barnea ER. Compositions and methods for the treatment of neurodamage. US11090355B2. 2021.","journal-title":"US11090355B2"},{"key":"e_1_3_3_94_1","article-title":"Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection","author":"Luthringer RH.","year":"2021","unstructured":"Luthringer RH. Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection. US11083723B2. 2021.","journal-title":"US11083723B2"},{"key":"e_1_3_3_95_1","article-title":"Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin","author":"Frey WH","year":"2021","unstructured":"Frey WH, 2nd, Hanson LRB, Byrnes K, et al. Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin. US10987423B2. 2021.","journal-title":"US10987423B2"},{"key":"e_1_3_3_96_1","article-title":"System and methods for treating brain related conditions with photobiomodulation therapy","author":"Chicchi MT.","year":"2021","unstructured":"Chicchi MT. System and methods for treating brain related conditions with photobiomodulation therapy. US10987521B1. 2021.","journal-title":"US10987521B1"},{"key":"e_1_3_3_97_1","article-title":"Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin","author":"Frey WH","year":"2021","unstructured":"Frey WH, 2nd, Hanson LRB, Byrnes K, et al. Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin. US10967061B2. 2021.","journal-title":"US10967061B2"},{"key":"e_1_3_3_98_1","article-title":"Furoxans as therapies for neurodegenerative disorders","author":"Schiefer I","year":"2021","unstructured":"Schiefer I, Shah Z. Furoxans as therapies for neurodegenerative disorders. US10913732B2. 2021.","journal-title":"US10913732B2"},{"key":"e_1_3_3_99_1","article-title":"Compositions and methods for inhibiting brain trauma-induced neurodegeneration and related conditions","author":"Becker RE.","year":"2020","unstructured":"Becker RE. Compositions and methods for inhibiting brain trauma-induced neurodegeneration and related conditions. US10864192B2. 2020.","journal-title":"US10864192B2"},{"key":"e_1_3_3_100_1","article-title":"Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach","author":"Byrne M","year":"2020","unstructured":"Byrne M, VanPelt AF. Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach. US10808247B2. 2020.","journal-title":"US10808247B2"},{"key":"e_1_3_3_101_1","article-title":"Compositions and methods for treating traumatic brain injury","author":"Baguisi A","year":"2020","unstructured":"Baguisi A, Beeuwkes R, Casale R, et al. Compositions and methods for treating traumatic brain injury. US10744115B2. 2020.","journal-title":"US10744115B2"},{"key":"e_1_3_3_102_1","article-title":"Steroid analogues for neuroprotection","author":"MacNevin C","year":"2020","unstructured":"MacNevin C, Stein DG, Liotta DC, et al. Steroid analogues for neuroprotection. US10716795B2. 2020.","journal-title":"US10716795B2"},{"key":"e_1_3_3_103_1","article-title":"Compounds and compositions for targeting brain injuries and methods of use thereof","author":"Ruoslahti E","year":"2020","unstructured":"Ruoslahti E, Mann A, Scodeller P, et al. Compounds and compositions for targeting brain injuries and methods of use thereof. US10653797B2. 2020.","journal-title":"US10653797B2"},{"key":"e_1_3_3_104_1","article-title":"Methods of treating mild brain injury","author":"Bansal V.","year":"2020","unstructured":"Bansal V. Methods of treating mild brain injury. US10617740B2. 2020.","journal-title":"US10617740B2"},{"key":"e_1_3_3_105_1","article-title":"Lipoyl-glu-ala for the treatment of neurodegenerative damage caused by traumatic brain injury","author":"Baguisl A","year":"2020","unstructured":"Baguisl A, Beeuwkes R, Casale R, et al. Lipoyl-glu-ala for the treatment of neurodegenerative damage caused by traumatic brain injury. EP3615023B1. 2020;AS.","journal-title":"EP3615023B1"},{"key":"e_1_3_3_106_1","article-title":"Method of treating traumatic brain injury with red\/NIR light","author":"Toselli R","year":"2020","unstructured":"Toselli R, DiMauro TM, Fisher M. Method of treating traumatic brain injury with red\/NIR light. US10561857B2. 2020.","journal-title":"US10561857B2"}],"container-title":["International Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00207454.2026.2620698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:00:30Z","timestamp":1777996830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00207454.2026.2620698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/00207454.2026.2620698"],"URL":"https:\/\/doi.org\/10.1080\/00207454.2026.2620698","relation":{},"ISSN":["0020-7454","1543-5245"],"issn-type":[{"value":"0020-7454","type":"print"},{"value":"1543-5245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ines20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ines20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}